Effect of cyclosporine coadministration on the pharmacokinetics of eltrombopag in healthy volunteers

Cancer Chemotherapy and Pharmacology
Vassilios AslanisTaoufik Ouatas

Abstract

Eltrombopag is indicated in patients with severe aplastic anemia (SAA) refractory to prior immunosuppressive therapy. The combination of eltrombopag and immunosuppressive therapy (such as cyclosporine) is currently being evaluated in patients with treatment-naive SAA. Cyclosporine is a human breast cancer resistance protein (BCRP) inhibitor, and can potentially alter plasma exposure to eltrombopag, a BCRP substrate. This phase 1, open-label, randomized, 3-period, crossover study evaluated the effect of cyclosporine on the pharmacokinetics of eltrombopag in healthy adults. Thirty-nine subjects were randomized to either single dose of eltrombopag 50 mg, cyclosporine 200 mg + eltrombopag 50 mg or cyclosporine 600 mg + eltrombopag 50 mg treatment groups. Eltrombopag pharmacokinetic parameters (Cmax, tmax, AUClast, AUCinf, %AUCex, t1/2, and CL/F) were determined using noncompartmental methods. Geometric mean AUCinf, AUClast, and Cmax, were decreased by 18, 20, and 25%, respectively, for cyclosporine 200 mg + eltrombopag and by 24, 22, and 39%, respectively, for cyclosporine 600 mg + eltrombopag groups compared to the eltrombopag alone group. The median tmax was prolonged by ~ 1 h in both coadministration treatments. The geometric me...Continue Reading

References

Jul 13, 2000·European Journal of Drug Metabolism and Pharmacokinetics·P A KellyH W Strobel
Jan 16, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cindy Q XiaLiang-Shang Gan
Mar 1, 2007·Blood·Julian M JenkinsConnie L Erickson-Miller
Jan 8, 2008·The American Journal of Gastroenterology·Michael B SternthalDaniel H Present
Jul 21, 2010·British Journal of Clinical Pharmacology·Gemma MatthysBin Peng
Mar 17, 2011·Journal of Clinical Pharmacology·Sam RebelloVenkateswar Jarugula
Mar 23, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kazuya TakeuchiYukio Kato
Mar 26, 2011·British Journal of Clinical Pharmacology·Alicia J AllredEdmund Lee
Apr 20, 2017·The New England Journal of Medicine·Danielle M TownsleyNeal S Young
Jun 28, 2018·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Daniel Valente NevesVera Lucia Lanchote

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.